s press releases go, this one was pretty standard: Recursion Pharmaceuticals Announces Funding for Rett Syndrome Research. What wasn’t standard was the short email that the company’s founder, Christopher Gibson, Ph.D., received back: “Our daughter is 38 months old—we hope you are successful.” Attached was a photo of a little girl on a tricycle.
For all the miraculous breakthroughs of medicine, the sober reality is that it’s never enough.
